HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank M Longo Selected Research

Macrophage Colony-Stimulating Factor

1/2019Receptor dependence of BDNF actions in superficial dorsal horn: relation to central sensitization and actions of macrophage colony stimulating factor 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank M Longo Research Topics

Disease

21Alzheimer Disease (Alzheimer's Disease)
05/2024 - 12/2002
7Huntington Disease (Huntington's Disease)
01/2023 - 08/2008
6Cognitive Dysfunction
12/2023 - 12/2002
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 08/2002
5Stroke (Strokes)
01/2022 - 07/2012
4Inflammation (Inflammations)
01/2021 - 11/2013
3Atrophy
01/2022 - 01/2014
3Rett Syndrome (Rett's Disorder)
11/2020 - 02/2012
3Disease Progression
01/2018 - 01/2014
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2018 - 05/2010
3Wounds and Injuries (Trauma)
12/2014 - 10/2002
3Neoplasms (Cancer)
12/2014 - 07/2008
3Spinal Cord Injuries (Spinal Cord Injury)
01/2013 - 02/2008
2Infarction (Infarctions)
01/2022 - 01/2018
2Seizures (Absence Seizure)
01/2022 - 02/2012
2Epilepsy (Aura)
01/2022 - 01/2018
2Ischemia
01/2021 - 01/2018
2Neurodevelopmental Disorders
11/2020 - 01/2017
2Neuroinflammatory Diseases
10/2019 - 01/2018
2Hyperalgesia
01/2019 - 08/2013
2Mental Disorders (Mental Disorder)
01/2018 - 03/2016
2Ischemic Stroke
01/2018 - 07/2012
1Vascular Calcification
12/2023
1Dementia (Dementias)
11/2022
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2022
1Erectile Dysfunction
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2020
1Tauopathies
01/2020
1Brain Neoplasms (Brain Tumor)
10/2019
1Herpes Zoster
01/2019
1Chemotherapy-Related Cognitive Impairment
01/2019
1Diarrhea
01/2019
1Hyperplasia
01/2019
1Blindness (Hysterical Blindness)
01/2019
1Neuralgia (Stump Neuralgia)
01/2019
1Mixed Dementias
01/2018
1Post-Traumatic Epilepsy (Epilepsy, Post Traumatic)
01/2018
1Alcoholism (Alcohol Abuse)
01/2016
1Binge Drinking
01/2016
1Cicatrix (Scar)
01/2015
1Peripheral Nervous System Diseases (PNS Diseases)
12/2014
1Contusions
01/2013
1Pain (Aches)
01/2013
1Apnea
02/2012
1Tachypnea
02/2012
1Nervous System Diseases (Neurological Disorders)
01/2009

Drug/Important Bio-Agent (IBA)

14Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
05/2024 - 10/2002
11Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2023 - 12/2007
11LigandsIBA
01/2021 - 12/2007
10LM11A-31IBA
01/2022 - 01/2013
6Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2022 - 08/2002
5Proteins (Proteins, Gene)FDA Link
12/2023 - 12/2007
5Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2015
5Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 01/2003
4Cholinergic Agents (Cholinergics)IBA
01/2022 - 04/2005
4Phosphotransferases (Kinase)IBA
11/2020 - 07/2012
3CytokinesIBA
01/2022 - 01/2019
3Retinaldehyde (Retinal)IBA
01/2021 - 06/2006
3TropomyosinIBA
11/2020 - 07/2012
3Nerve Growth Factor (NGF)IBA
01/2019 - 12/2007
2trkB ReceptorIBA
01/2022 - 11/2020
2N,N',N'- tris(2- hydroxyethyl)- 1,3,5- benzenetricarboxamideIBA
01/2022 - 07/2012
2Therapeutic UsesIBA
01/2021 - 08/2013
2Methyl-CpG-Binding Protein 2IBA
11/2020 - 02/2012
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2018
2Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 07/2008
2ParvalbuminsIBA
01/2018 - 11/2013
2Cisplatin (Platino)FDA LinkGeneric
12/2014 - 07/2008
2rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
12/2014 - 01/2009
2Peptides (Polypeptides)IBA
10/2011 - 06/2006
2Amyloid beta-PeptidesIBA
08/2009 - 01/2004
2Neuroprotective AgentsIBA
07/2008 - 01/2004
1trkC ReceptorIBA
01/2023
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2022
1Phosphodiesterase 5 InhibitorsIBA
01/2021
1SynucleinsIBA
01/2020
1Tight Junction ProteinsIBA
01/2019
1Serotonin (5 Hydroxytryptamine)IBA
01/2019
1Macrophage Colony-Stimulating FactorIBA
01/2019
1Claudin-5IBA
01/2019
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2018
1salicylhydroxamic acid (SHAM)IBA
01/2018
1Neuregulin-1 (Neuregulin 1)IBA
01/2018
1Complement System Proteins (Complement)IBA
01/2017
1Methionine (L-Methionine)FDA Link
03/2016
1Valine (L-Valine)FDA Link
03/2016
1Small Interfering RNA (siRNA)IBA
01/2016
1Oligoclonal BandsIBA
02/2015
1Chondroitin Sulfate ProteoglycansIBA
01/2015
1Monomeric GTP-Binding ProteinsIBA
01/2009

Therapy/Procedure

5Therapeutics
10/2023 - 01/2013
4Oral Administration
01/2022 - 01/2013
1Prostatectomy (Retropubic Prostatectomy)
01/2021
1Radiotherapy
10/2019
1Drug Therapy (Chemotherapy)
01/2019
1Injections
01/2018
1Withholding Treatment
12/2014